US$ 20.48
glp-1 therapy for diabetes + Gastrin: Next gen regenerative GLP-1-based therapies for diabetes, obesity
Description
If the provider determines that a client is not medically eligible for treatment, the program fee will be refunded minus a $50 consultation fee for the completed medical review

In comparison to traditional GLP-1RAs, these theranostic platforms introduce a level of control and personalization not achievable through pharmacologic means alone

Endocrinology 158:41394151

The actual monthly rate for compounded semaglutide is $299, making the claim roughly accurate